Zacks Investment Research upgraded shares of Jaguar Animal Health, Inc. (NASDAQ:JAGX) from a sell rating to a hold rating in a research report released on Tuesday morning.

According to Zacks, “Jaguar Animal Health, Inc. is an animal health company. The company is engaged in developing and commercializing gastrointestinal products for companion and production animals. Its pipeline of prescription drug product includes Canalevia(TM), species-specific formulations of crofelemer, Virend and species-specific formulations of NP-500. The Company’s non-prescription products comprises of Neonorm(TM) Calf and species-specific formulations of Neonorm. Jaguar Animal Health, Inc. is headquartered in San Francisco, California. “

Jaguar Animal Health (NASDAQ:JAGX) traded down 4.179% during midday trading on Tuesday, reaching $0.642. The company’s stock had a trading volume of 84,108 shares. The firm’s market cap is $7.92 million. Jaguar Animal Health has a 52 week low of $0.61 and a 52 week high of $4.60. The firm has a 50 day moving average price of $0.71 and a 200-day moving average price of $1.20.

ILLEGAL ACTIVITY WARNING: “Jaguar Animal Health, Inc. (JAGX) Raised to Hold at Zacks Investment Research” was originally posted by Watch List News and is the propert of of Watch List News. If you are reading this report on another website, it was illegally stolen and reposted in violation of United States & international copyright legislation. The correct version of this report can be read at

About Jaguar Animal Health

Jaguar Animal Health, Inc is an animal health company focused on developing and commercializing gastrointestinal products for companion and production animals, and horses. The Company is developing a formulation of a Croton lechleri product for the treatment of ulcers in horses. It is developing a pipeline of prescription drug product candidates and non-prescription (non-drug) products.

5 Day Chart for NASDAQ:JAGX

Get a free copy of the Zacks research report on Jaguar Animal Health (JAGX)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Jaguar Animal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Animal Health Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.